Frequency of Deletions of EPCAM (TACSTD1) in MSH2-Associated Lynch Syndrome Cases

Lynch syndrome is an autosomal dominant cancer predisposition syndrome characterized by loss of function of DNA mismatch repair enzyme MLH1, MSH2, MSH6, or PMS2. Mutations in MLH1 and MSH2 account for ∼80% of the inherited cases. However, in up to 20% of cases suspected of having a germline mutation...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Rumilla, Kandelaria, Schowalter, Karen V., Lindor, Noralane M., Thomas, Brittany C., Mensink, Kara A., Gallinger, Steven, Holter, Spring, Newcomb, Polly A., Potter, John D., Jenkins, Mark A., Hopper, John L., Long, Tiffany I., Weisenberger, Daniel J., Haile, Robert W., Casey, Graham, Laird, Peter W., Le Marchand, Loic, Thibodeau, Stephen N.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Investigative Pathology 2011
Matèries:
Regular Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3069927/
https://ncbi.nlm.nih.gov/pubmed/21227399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmoldx.2010.11.011
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars